📄 "EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T (REG) -DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL" . EBV ( December 3, 2025 at 10:47AM)
https://pubmed.ncbi.nlm.nih.gov/41332545/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251203084721&v=2.18.0.post22+67771e2

📄 "Descriptive Study of Tumor Immune Microenvironment and Epstein-Barr Virus Infection in Gastric Adenocarcinoma" . EBV ( December 4, 2025 at 09:47AM)
https://pubmed.ncbi.nlm.nih.gov/41341193/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251204074744&v=2.18.0.post22+67771e2

📄 "Influence of blood EBV-DNA level on survival of patients with nasopharyngeal cancer on immune checkpoint inhibitors: a meta-analysis" . EBV ( December 4, 2025 at 06:30AM)
https://pubmed.ncbi.nlm.nih.gov/41339904/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251204043058&v=2.18.0.post22+67771e2

📄 "Epstein-Barr virus and multiple sclerosis: A mechanism comes into focus" . EBV ( November 28, 2025 at 10:15PM)
https://pubmed.ncbi.nlm.nih.gov/41313861/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251128201546&v=2.18.0.post22+67771e2

📄 "Epstein-Barr virus infection shapes the genetic, transcriptomic, and immune microenvironment landscape of Burkitt lymphoma" . Vírus e Câncer ( December 11, 2025 at 03:53AM)
https://pubmed.ncbi.nlm.nih.gov/41372946/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20251211015355&v=2.18.0.post22+67771e2

📄 "Epstein-Barr virus infection shapes the genetic, transcriptomic, and immune microenvironment landscape of Burkitt lymphoma" . EBV ( December 11, 2025 at 04:53AM)
https://pubmed.ncbi.nlm.nih.gov/41372946/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251211025357&v=2.18.0.post22+67771e2

📄 "Redefining the Spectrum of EBV-Positive Diffuse Large B-Cell Lymphoma and EBV-Positive Classic Hodgkin Lymphoma" . EBV ( December 11, 2025 at 04:53AM)
https://pubmed.ncbi.nlm.nih.gov/41371409/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251211025357&v=2.18.0.post22+67771e2

📄 "EBV-LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC-Mediated Activation of PI3K/Akt Pathway" . EBV ( December 22, 2025 at 05:02PM)
https://pubmed.ncbi.nlm.nih.gov/41427845/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251222150243&v=2.18.0.post22+67771e2

📄 "Host immunogenetics and EBV detection in cancer: the CTLA-4 rs231775 signal in a multi-cancer case-control cohort" . EBV ( December 23, 2025 at 12:24PM)
https://pubmed.ncbi.nlm.nih.gov/41430705/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251223102431&v=2.18.0.post22+67771e2

📄 "Dissecting Epstein-Barr Virus Dependence Across Diverse Infected Cell Models" . EBV ( December 25, 2025 at 10:13AM)
https://pubmed.ncbi.nlm.nih.gov/41446165/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251225081322&v=2.18.0.post22+67771e2

📄 "Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases" . Int J Cancer ( December 26, 2025 at 05:22AM)
https://onlinelibrary.wiley.com/doi/10.1002/ijc.70305?af=R

📄 "The Many Faces of Primary EBV Infection: A Case Series of Its Diverse Presentations" . EBV ( December 30, 2025 at 10:37AM)
https://pubmed.ncbi.nlm.nih.gov/41464649/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251230083742&v=2.18.0.post22+67771e2

📄 "Clinicopathological Study of Hodgkin Lymphoma in Relation to Programmed Death-Ligand 1 (PD-L1) Expression and Epstein-Barr Virus (EBV) Status" . Vírus e Câncer ( January 1, 2026 at 11:48AM)
https://pubmed.ncbi.nlm.nih.gov/41477414/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260101094853&v=2.18.0.post22+67771e2

📄 "Epstein-Barr Virus Promotes Gastric Cancer Progression by Modulating m6A-Dependent YTHDF1-TSC22D1 Axis" . ⭐ Virus and Cancer Progression ( December 31, 2025 at 12:47PM)
https://pubmed.ncbi.nlm.nih.gov/41472023/?utm_source=Feedly&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1ru3PjCROMN0-DCYXXwG3ZQiiaCRebQ72s7IemRCfW7HQFT5bF&fc=20250206153036&ff=20251231104714&v=2.18.0.post22+67771e2

📄 "Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosis" . EBV ( January 24, 2026 at 02:59AM)
https://pubmed.ncbi.nlm.nih.gov/41576916/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260124005911&v=2.18.0.post22+67771e2

📄 "Cat viruses as windows into human oncogenesis" . Nature Rev Cancer ( January 23, 2026 at 06:32PM)
https://www.nature.com/articles/s41568-026-00909-z

📄 "Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-kappaB pathway" . EBV ( January 26, 2026 at 08:24PM)
https://pubmed.ncbi.nlm.nih.gov/41587214/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260126182420&v=2.18.0.post22+67771e2

📄 "KSHV and cancer: understanding the oncogenic machinery for next-generation diagnostic tools and therapies" . KSHV/HHV-8 ( January 21, 2026 at 03:49PM)
https://pubmed.ncbi.nlm.nih.gov/41563473/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260121134907&v=2.18.0.post22+67771e2

📄 "Expanding the Global Landscape of Epstein-Barr Virus Genomes: A Call for Greater Representation" . EBV ( January 12, 2026 at 04:36PM)
https://pubmed.ncbi.nlm.nih.gov/41524218/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260112143559&v=2.18.0.post22+67771e2

📄 "Profiling and functional analysis of exosomal circRNAs from EBV-associated gastric carcinoma CSCs" . EBV ( January 8, 2026 at 10:56PM)
https://pubmed.ncbi.nlm.nih.gov/41504772/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260108205620&v=2.18.0.post22+67771e2

📄 "Clinicopathologic Analysis of 34 Japanese Patients With EBV-Associated Reactive Lymphoid Hyperplasias" . EBV ( January 7, 2026 at 04:44AM)
https://pubmed.ncbi.nlm.nih.gov/41495022/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260107024409&v=2.18.0.post22+67771e2